feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact",https://benzinga.com/general/biotech/22/07/27930613/the-daily-biotech-pulse-fda-wants-omicron-targeted-covid-19-boosters-provention-bio-hits-hurdle-f,https://bit.ly/3QZvlBJ
Benzinga,FDA Turns Down NRx Pharmaceuticals' Emergency Use Submission For Covid-19 Candidate,https://benzinga.com/general/biotech/22/07/27930848/fda-turns-down-nrx-pharmaceuticals-emergency-use-submission-for-covid-19-candidate,https://bit.ly/3Ai8qeV
